Thursday, June 22, 2017 5:00 am
SAN DIEGO — University of Oklahoma Venture Fellow Blake Hopiavuori reflected upon the end of a long day combing the massive BIO 2017 biotechnology show here as he sat in the OKBio pavilion late Tuesday afternoon.
“We had a great day today,” Hopiavuori said. “We found a completely new market today that we hadn't even thought about, not even a little bit.”
Hopiavuori and two other Venture Fellows in OU's Office of Technology development — Cortes Williams and Dustin Masser — are working to commercialize technologies they developed while earning their Ph.D.'s at OU.
The OU trio was back on the floor of the show Wednesday morning, meeting fellow researchers, checking out potential competitors to their technologies and making presentations in the Oklahoma Bioscience Association's pavilion.
Williams co-founded a company called NextGen Medical to commercialize technology he developed that facilitates assessment of effectiveness of cancer therapeutics by health care professionals.
Hopiavuori and Masser are working together to develop a natural skin molecule that can promote wound healing and other potential skin benefits.